AMH and myeloid sarcoma: There was no difference between levels of FSH, LH, inhibits, estrogen, progesterone, free testosterone, anti-Müllerian hormone (AMH), or ovarian reserve in women with controlled MS or without the disease. However, patients with uncontrolled disease and subjects with active MS had smaller ovaries with fewer follicles and decreased AMH levels.